These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 15124331)

  • 41. Showcasing bioscience in Rhode Island.
    Spero D
    R I Med J (2013); 2013 Feb; 96(2):15. PubMed ID: 23641419
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genzyme deal set to alter biotech landscape.
    Ledford H
    Nature; 2011 Feb; 470(7335):449. PubMed ID: 21350458
    [No Abstract]   [Full Text] [Related]  

  • 43. Bioscience industry in metro Atlanta.
    Allen CR
    Drug Discov Today; 2005 Feb; 10(4):237-9. PubMed ID: 15708740
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mission possible: managing innovation in drug discovery.
    Zhong X; Moseley GB
    Nat Biotechnol; 2007 Aug; 25(8):945-6. PubMed ID: 17687373
    [No Abstract]   [Full Text] [Related]  

  • 45. The fundamentals of flexibility.
    Butler TW; Ewald J
    Hosp Top; 2000; 78(3):11-8. PubMed ID: 11139899
    [No Abstract]   [Full Text] [Related]  

  • 46. For success, focus your strengths.
    Levinson AD
    Nat Biotechnol; 1998 May; 16 Suppl():45-6. PubMed ID: 9591268
    [No Abstract]   [Full Text] [Related]  

  • 47. Merck wipes Serono off Swiss biotech map.
    Urquhart L
    Nat Biotechnol; 2006 Nov; 24(11):1303. PubMed ID: 17093457
    [No Abstract]   [Full Text] [Related]  

  • 48. Merck hires top academic geneticist.
    Nowak R
    Science; 1994 Oct; 266(5185):538. PubMed ID: 7939697
    [No Abstract]   [Full Text] [Related]  

  • 49. Roche vows to keep Genentech culture.
    Hayden EC
    Nature; 2009 Mar; 458(7236):270. PubMed ID: 19295574
    [No Abstract]   [Full Text] [Related]  

  • 50. Cheap at any price?
    Ledford H
    Nature; 2007 May; 447(7141):131. PubMed ID: 17495898
    [No Abstract]   [Full Text] [Related]  

  • 51. Rediscovering plant-based drugs.
    Littleton J; Falcone D; Davies HM
    Nat Biotechnol; 2003 Aug; 21(8):843-4. PubMed ID: 12894188
    [No Abstract]   [Full Text] [Related]  

  • 52. Biogen Idec restructures, sharpens neurology focus.
    Mitchell P
    Nat Biotechnol; 2011 Jan; 29(1):7-8. PubMed ID: 21221080
    [No Abstract]   [Full Text] [Related]  

  • 53. Lilly goes off Prozac.
    Simons J
    Fortune; 2004 Jun; 149(13):179-80, 182, 184. PubMed ID: 15241951
    [No Abstract]   [Full Text] [Related]  

  • 54. Paring down the company: the effect of consolidation in the European biotech sector.
    Bassett P
    Nat Biotechnol; 2003 Jul; 21(7):829-30. PubMed ID: 12833105
    [No Abstract]   [Full Text] [Related]  

  • 55. On the road to California.
    DeWitt N
    Nature; 2002 Dec; 420(6916 Suppl):A9. PubMed ID: 12510695
    [No Abstract]   [Full Text] [Related]  

  • 56. Biopharma business models in Canada.
    March-Chordà I; Yagüe-Perales RM
    Drug Discov Today; 2011 Aug; 16(15-16):654-8. PubMed ID: 21708279
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Profile: Corey Goodman.
    Kling J
    Nat Biotechnol; 2009 Apr; 27(4):308. PubMed ID: 19352358
    [No Abstract]   [Full Text] [Related]  

  • 58. Big biotech buys iconic genetics firm.
    Baker M
    Nature; 2012 Dec; 492(7429):321. PubMed ID: 23257857
    [No Abstract]   [Full Text] [Related]  

  • 59. A time for growth: an interview with Amgen CEO Kevin Sharer. Interview by Paul Hemp.
    Sharer K
    Harv Bus Rev; 2004; 82(7-8):66-74, 186. PubMed ID: 15241953
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biotech boot camp.
    Ledford H
    Nature; 2015 Mar; 519(7544):402-5. PubMed ID: 25810186
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.